07:30 AM EDT, 07/22/2025 (MT Newswires) -- Quest Diagnostics ( DGX ) reported Q2 adjusted earnings Tuesday of $2.62 per share, up from $2.35 a year earlier.

Analysts surveyed by FactSet expected $2.57.

Revenue for the three months ended June 30 was $2.76 billion, up from $2.40 billion last year.

Analysts surveyed by FactSet expected $2.73 billion.

The company now expects full-year net revenue of $10.80 billion to $10.92 billion, up from prior guidance of $10.70 billion to $10.85 billion. Analysts surveyed by FactSet expect $10.80 billion.

Adjusted EPS for 2025 is now expected to be $9.63 to $9.83, compared with the previous range of $9.55 to $9.80. Analysts polled by FactSet estimate $9.70.

Shares of the company were up by over 3.1% in recent Tuesday premarket activity.